IFNG and Alzheimer disease: Research has focused on the impact of priming or pre-conditioning AD-MSCs with pro-inflammatory cytokines, such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNFα), on their immunomodulatory capabilities.